Ascopharm Groupe Novasco   Report issue

For profit Phase 2 Phase 3
Founded: Paris France (1995)

Organization Overview

First Clinical Trial
2010
NCT01175200
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

leucovorin (1 trial)

levothyroxine (Synthroid) (1 trial)

Drugs in Phase 2 Trials (1)

pxt00864 (2 trials)

Drugs in Other Trials (3)

clopidogrel (plavix) (1 trial)

lansoprazole (prevacid) (1 trial)

prasugrel (effient) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Down Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6